Main > A1. CORP. INDEX. D-Dm > Daiichi Sankyo/P C2

---

This data is not available for free

Daiichi Sankyo/P C2's subsections
2007. 09.27.2007. CV.
2008. 01.18.2008. Diabetes
2008. 02.20.2008. CV>ACS>PCI
2008. 03.12.2008. AnAlgesics; SAID
2008. 03.26.2008. Ab Drugs Research
2008. 06.16.2008. Corp. Acq.
2008. 12.01.2008. CEO Of U.S. Arm
2009. 06.01.2009. CEO
2012. 03.02.2012. GSK Vaccine JV
2012. 03.29.2012. NGM Biopharma.
2012. 06.20.2012. Ranbaxy Venezuela
2012. 08.26.2012. CV>ACS>UA/NSTEMI
2014. 01.09. Virtici LLC
2014. 02.14. UMN Pharma Inc.
2014. 04.03. UCSF
2014. 05.14. MRC Technology
2014. 05.22. Sanford Burnham
2014. 09.26. AntiCoagulant>Edoxaban
2015. 01.09. AntiCoagulant>Edoxaban
2015. 04.20. Sell Sun Pharma
2015. 11.10. Onco.>Melanoma
2017. 02.10. Close Asubio Pharma
2017. 04.27. ADC Onco.
2018. 06.06. Benicar
2019. 08.05. Onco.>TGCT
2020. 09.25. Onco.>Gastric C.
2021. 05.06. Hemato.>Fe Def. Anemia
2022. 08.05. Onco.>Breast C.>USA>OK
2022. 08.11. Onco.>Lung C.>USA>OK
2022. 09.26. Onco.>Leu/Lym>JP>OK
2023. 07.20. FLT3-ITD+ AML>USA>OK
Daiichi Sankyo Chemical Pharma C2
Daiichi Sankyo Europe GmbH C2
Web-Site (Brazil)
Web-Site (Europe)
Web-Site (Japan)
Web-Site (USA)
Z - OK

Daiichi Sankyo/P C2's products
This section has no products